Insights and updates on precision medicine, drug discovery, genomics, and clinical research.
The moment that sparked Crick happened in a hospital waiting room. A friend had just been diagnosed with a rare form of cancer, and her oncologist mentioned there might be clinical trials worth exploring.
Medical knowledge has traditionally been organized like an encyclopedia. But biology doesn't work like an encyclopedia—biology is a network.
You paid $99 for that 23andMe test and got some interesting ancestry results. But that raw genetic data file contains something far more valuable.
You've found a promising clinical trial, but it says "Phase 2." What does that mean, and should you consider enrolling?
Ever wondered what your medication actually looks like at the molecular level? Or why two drugs that seem similar have completely different side effects?
A story that spans decades of research, millions of research dollars, thousands of scientists, and ultimately, lives saved.
You've found a promising clinical trial that makes biological sense for your condition. Then you see the locations: Houston, Boston, Seattle. You live in rural Montana.
Explore how precision medicine is revolutionizing healthcare by tailoring treatments to individual genetic profiles and disease characteristics.
An interactive forecast exploring how artificial intelligence will reshape healthcare professions over the next decade—revealing surprising winners, losers, and the irreplaceable human elements.